Journal of Korean Neurosurgical Society

  • 제67권3호
  • /
  • Pages.364-375
  • /
  • 2024
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

High Expression of KIFC1 in Glioma Correlates with Poor Prognosis

  • Pengfei Xue (Department of Neurosurgery, Liaocheng People's Hospital) ;
  • Juan Zheng (Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital) ;
  • Rongrong Li (Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital) ;
  • Lili Yan (Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital) ;
  • Zhaohao Wang (Department of Neurosurgery, Yantaishan Hospital Affiliated to Binzhou Medical University) ;
  • Qingbin Jia (Department of Neurosurgery, Liaocheng People's Hospital) ;
  • Lianqun Zhang (Department of Neurosurgery, Liaocheng People's Hospital) ;
  • Xin Li (Department of Neurosurgery, Liaocheng People's Hospital)
  • 투고 : 2023.07.20
  • 심사 : 2023.10.19
  • 발행 : 2024.05.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : Kinesin family member C1 (KIFC1), a non-essential kinesin-like motor protein, has been found to serve a crucial role in supernumerary centrosome clustering and the progression of several human cancer types. However, the role of KIFC1 in glioma has been rarely reported. Thus, the present study aimed to investigate the role of KIFC1 in glioma progression. Methods : Online bioinformatics analysis was performed to determine the association between KIFC1 expression and clinical outcomes in glioma. Immunohistochemical staining was conducted to analyze the expression levels of KIFC1 in glioma and normal brain tissues. Furthermore, KIFC1 expression was knocked in the glioma cell lines, U251 and U87MG, and the functional roles of KIFC1 in cell proliferation, invasion and migration were analyzed using cell multiplication, wound healing and Transwell invasion assays, respectively. The autophagic flux and expression levels matrix metalloproteinase-2 (MMP2) were also determined using imaging flow cytometry, western blotting and a gelation zymography assay. Results : The results revealed that KIFC1 expression levels were significantly upregulated in glioma tissues compared with normal brain tissues, and the expression levels were positively associated with tumor grade. Patients with glioma with low KIFC1 expression levels had a more favorable prognosis compared with patients with high KIFC1 expression levels. In vitro, KIFC1 knockdown not only inhibited the proliferation, migration and invasion of glioma cells, but also increased the autophagic flux and downregulated the expression levels of MMP2. Conclusion : Upregulation of KIFC1 expression may promote glioma progression and KIFC1 may serve as a potential prognostic biomarker and possible therapeutic target for glioma.

키워드

참고문헌

  1. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. : Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 : 756-760, 2006 
  2. Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M : GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol 19 : 139-141, 2017 
  3. Conduit PT, Wainman A, Raff JW : Centrosome function and assembly in animal cells. Nat Rev Mol Cell Biol 16 : 611-624, 2015 
  4. Dai J, Bing Z, Zhang Y, Li Q, Niu L, Liang W, et al. : Integrated mRNAseq and microRNAseq data analysis for grade III gliomas. Mol Med Rep 16 : 7468-7478, 2017 
  5. Diwanji TP, Engelman A, Snider JW, Mohindra P : Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults. Adolesc Health Med Ther 8 : 99-113, 2017 
  6. Dong W, Li H, Zhang Y, Yang H, Guo M, Li L, et al. : Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Acta Biochim Biophys Sin (Shanghai) 43 : 840-848, 2011 
  7. Fu X, Zhu Y, Zheng B, Zou Y, Wang C, Wu P, et al. : KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. Int J Oncol 52 : 1912-1922, 2018 
  8. Global Burden of Disease Cancer Collaboration; Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. : Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3 : 524-548, 2017 
  9. Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Hajduch M, et al. : The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res 15 : 1755-1761, 2009 
  10. Han J, Wang F, Lan Y, Wang J, Nie C, Liang Y, et al. : KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling. Oncogene 38 : 406-420, 2019 
  11. Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, et al. : Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 11 : 5084-5089, 2005 
  12. Kleylein-Sohn J, Pollinger B, Ohmer M, Hofmann F, Nigg EA, Hemmings BA, et al. : Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET. J Cell Sci 125(Pt 22) : 5391-5402, 2012 
  13. Klionsky DJ : Autophagy revisited: a conversation with Christian de Duve. Autophagy 4 : 740-743, 2008 
  14. Levine MS, Bakker B, Boeckx B, Moyett J, Lu J, Vitre B, et al. : Centrosome amplification is sufficient to promote spontaneous tumorigenesis in mammals. Dev Cell 40 : 313-322.e5, 2017 
  15. Li Y, Lu W, Chen D, Boohaker RJ, Zhai L, Padmalayam I, et al. : KIFC1 is a novel potential therapeutic target for breast cancer. Cancer Biol Ther 16 : 1316-1322, 2015 
  16. Liu Y, Pelletier L : A magic bullet for targeting cancers with supernumerary centrosomes. EMBO J 38 : e101134, 2019 
  17. Liu Y, Zhan P, Zhou Z, Xing Z, Zhu S, Ma C, et al. : The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer. J Thorac Dis 8 : 2911-2923, 2016 
  18. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. : The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 : 97-109, 2007 
  19. Mittal K, Choi DH, Klimov S, Pawar S, Kaur R, Mitra AK, et al. : A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas. J Ovarian Res 9 : 17, 2016 
  20. Pallichankandy S, Rahman A, Thayyullathil F, Galadari S : ROS-dependent activation of autophagy is a critical mechanism for the induction of anti-glioma effect of sanguinarine. Free Radic Biol Med 89 : 708-720, 2015 
  21. Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, et al. : KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries. J Ovarian Res 7 : 53, 2014 
  22. Rath O, Kozielski F : Kinesins and cancer. Nat Rev Cancer 12 : 527-539, 2012 
  23. Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, et al. : KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer. J Clin Med 8 : 225, 2019 
  24. Sekino Y, Oue N, Shigematsu Y, Ishikawa A, Sakamoto N, Sentani K, et al. : KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer. Urol Oncol 35 : 31.e13-31.e20, 2017 
  25. Shin SY, Lee KS, Choi YK, Lim HJ, Lee HG, Lim Y, et al. : The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis 34 : 2080-2089, 2013 
  26. Tang Z, Kang B, Li C, Chen T, Zhang Z : GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47(W1) : W556-W560, 2019 
  27. Teng K, Wei S, Zhang C, Chen J, Chen J, Xiao K, et al. : KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity. J Exp Clin Cancer Res 38 : 329, 2019 
  28. Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP, et al. : Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer 17 : 434, 2017 
  29. Wen ZP, Zeng WJ, Chen YH, Li H, Wang JY, Cheng Q, et al. : Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. J Exp Clin Cancer Res 38 : 298, 2019 
  30. Xiao KH, Teng K, Ye YL, Tan L, Chen MK, Liang HT, et al. : Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling. Cancer Sci 110 : 2822-2833, 2019 
  31. Xiao YX, Yang WX : KIFC1: a promising chemotherapy target for cancer treatment? Oncotarget 7 : 48656-48670, 2016 
  32. Yu Y, Feng YM : The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer 116 : 5150-5160, 2010 
  33. Zhang H, Ma Y, Wang H, Xu L, Yu Y : MMP-2 expression and correlation with pathology and MRI of glioma. Oncol Lett 17 : 1826-1832, 2019 
  34. Zhou K, Zhao J, Qi L, He Y, Xu J, Dai M : Kinesin family member C1 (KIFC1) accelerates proliferation and invasion of endometrial cancer cells through modulating the PI3K/AKT signaling pathway. Technol Cancer Res Treat 19 : 1533033820964217, 2020